期刊文献+

雾化吸入药代动力学试验护理配合的经验总结与探讨

Experience summary and discussion on nursing collaboration in pharmacokinetic trials of nebulized inhalation formulations
原文传递
导出
摘要 目的 总结雾化吸入制剂药代动力学试验中健康受试者的规范化用药管理流程,探讨护理配合要点.方法 针对中山大学孙逸仙纪念医院开展的一项雾化吸入制剂的改良型新药药代动力学研究的试验过程展开回顾性分析与探讨.结果 操作一致性、受试者的配合、环境控制以及用药剂量监测等因素是雾化制剂药代动力学试验护理管理的关键及难点.结论 研究护士的规范化给药过程及护理配合是保证雾化吸入药代动力学试验顺利完成的重要环节,进一步为临床试验提供更准确的数据. Objective To summarize the standardized medication management process for healthy subjects in pharmacokinetic trials of nebulized inhalation formulations and explore key nursing collaboration points.Methods A retrospective analysis and discussion were conducted on the trial process of a new drug,which underwent formulation improvement to a nebulized inhalation formulation,in pharmacokinetic research conducted at our institution.Results Factors such as operational consistency,subject cooperation.environmental control,and medication dose monitoring were identified as key challenges in the nursing management of pharmacokinetic trials involving nebulized formulations.Conc lusion Standardized medication administration processes and nursing collaboration are crucial for ensuring the smooth completion of pharmacokinetic trials involving nebulized inhalation,further enhancing the accuracy of data for clinical trials.
作者 严丽红 陈淑萍 陈珺仪 Yan Lihong;Chen Shuping;Chen Junyi(Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou,Guangdong 510120,China)
出处 《首都食品与医药》 2024年第17期151-154,共4页 Capital Food Medicine
关键词 雾化吸入制剂 药代动力学试验 护理 aerosol inhalation preparation pharmacokinetic test medication management
  • 相关文献

参考文献10

二级参考文献90

  • 1孙明利,王进,宋秀霞,白海红,刘慧娟,刘晨,佟媛旭,王泽娟,刘晓娜,王瑜,李岩,李银娟,陈刚,李璞,黄俊,王兴河.盐酸二甲双胍普通片和缓释片在中国健康受试者中的安全性分析[J].中国新药杂志,2020,29(4):399-407. 被引量:7
  • 2田治科,潘一斌,黄雅琴.吸入粉雾剂给药装置的研究进展[J].中国药业,2005,14(1):23-24. 被引量:8
  • 3熊亮,陶晓南.气道高反应性发生机制及与之相关临床疾病[J].国际呼吸杂志,2006,26(3):223-225. 被引量:39
  • 4[1]Tatsumara T, Kngama S, Taujimoto M. Further study of nebulization chemotherapy, a new chemotherapeutic method in the treament of lung carcinomas: fundamental and clinical [J]. Br J Cancer, 1993,68(6): 1146~1149.
  • 5[3]Hershey AE, Kurzman ID, Forrest LJ. Inhalation chemotherapy for macroscopic primary or metastatic lung tumors:proof of principle using dogs with spontaneously occurring tumors as a model [J]. Clin Cancer Res, 1999,5:2653~2659.
  • 6[4]Koshkina NV, Gilbert BE, Waldrep JC. Distribution of camptothecin after delivery as a liposome aerosol or following intramuscular injection in mice[J]. Cancer Chenother Pharmacol, 1999,44(3): 187~192.
  • 7[5]HulandE, HeinzerH, HulandH. Overviewofinterleukin-2inhalation therapy [J ]. Cancer J Sci Am, 2000, 6 ( S1 ): S104~S112.
  • 8[6]Enk AH, NashanD, RubbenA. Highdoseinterleukin-2 therapy for lung metastases in patients with malignant melanoma[J].Cancer, 2000,88 (9): 2042~2046.
  • 9[7]Smithson WA, Burch P, Gomet M. Aerosol granulocyte macrophage-colony stimulating factor: a low toxicity, lung-specific biological therapy in patients with lung metastases[J ]. Clin Cancer Res, 1999,5:2316~2323.
  • 10王秋萍,陈伟,李泽卿.上气道咳嗽综合征的病因及诊治[J].中华结核和呼吸杂志,2009,32(6):405-406. 被引量:18

共引文献462

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部